MSH2 and neoplasm: Moreover, all combinations of baculovirus-produced wild-type and mutant human MSH2 and MSH6 performed equally well in an in vitro mismatch repair assay and SIFT analysis classified all three variants as neutral [35], indicating that none of the three mutations caused tumor predisposition.